The burgeoning popularity of semaglutide , initially for diabetes , is creating significant interest within the British Isles, prompting a notable shift in medication trends. Access these treatments remains a complex challenge , with NHS approval currently limited and independent providers offering treatment at a higher cost . Concerns are being ra